Moderna (MRNA) obliterated Covid vaccine sales forecasts on Wednesday and reported better-than-expected quarterly profit, leading Moderna stock to surge. X The company retained its full-year outlook f...
Moderna (MRNA) obliterated Covid vaccine sales forecasts on Wednesday and reported better-than-expected quarterly profit, leading Moderna stock to surge. X The company retained its full-year outlook f...